Teams at some medical centers are investigating CAR T-cell therapies that have not yet been approved by the FDA. These therapies may be available to you if you agree to participate in a clinical trial that is testing the therapy's safety and effectiveness.
For example, some centers are researching whether using CAR T-cells made from T-cells provided by a donor rather than the patient is a safe and effective treatment.
For more information about CAR T-cell therapy clinical trials, contact the NMDP Jason Carter Clinical Trial Program or call 888-814-8610.
The Leukemia & Lymphoma Society also has navigators who can help you find a clinical trial that’s right for you. Request support online or call 800-955-4572.
Clinicaltrials.gov, a website hosted by the National Institutes of Health, provides details about clinical trials worldwide
Updated November 2024
